Aster DM Healthcare plans to invest roughly Rs 900 crore in capital expenditure over the next three years to increase its footprint in India, with the goal of raising income from the nation to around 40% of overall sales by 2025, according to a top company official.
The company said last week that its consolidated net profit for the quarter ending September 2021 increased by more than threefold to Rs 127.62 crore. During the quarter, revenue from operations was Rs 2,504.34 crore.
Aster DM Healthcare Founder Chairman and MD Azad Moopen said”For the last few quarters, or even since the last one year, we have been very aggressively looking at India, so we know that India is a market with huge potential which has got significant demand and supply gap…so it makes very easy to take that decision to look at India as the long term growth market for us.”
